Preclinical evaluation of the novel multi-targeted agent R1530.

MLA

Kolinsky, Kenneth, et al. “Preclinical Evaluation of the Novel Multi-Targeted Agent R1530.” Cancer Chemotherapy & Pharmacology, vol. 68, no. 6, Dec. 2011, pp. 1585–94. EBSCOhost, https://doi.org/10.1007/s00280-011-1608-x.

APA

Kolinsky, K., Tovar, C., Zhang, Y.-E., Railkar, A., Yang, H., Carvajal, D., Nevins, T., Geng, W., Linn, M., Packman, K., Liu, J.-J., Zhang, Z., Wovkulich, P., Ju, G., & Higgins, B. (2011). Preclinical evaluation of the novel multi-targeted agent R1530. Cancer Chemotherapy & Pharmacology, 68(6), 1585–1594. https://doi.org/10.1007/s00280-011-1608-x

Chicago

Kolinsky, Kenneth, Christian Tovar, Yu-E Zhang, Aruna Railkar, Hong Yang, Daisy Carvajal, Thomas Nevins, et al. 2011. “Preclinical Evaluation of the Novel Multi-Targeted Agent R1530.” Cancer Chemotherapy & Pharmacology 68 (6): 1585–94. doi:10.1007/s00280-011-1608-x.